Report Materials
Lancaster General Hospital received overpayments totaling $114,000 for oxaliplatin drug services provided during calendar year 2005.
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.